Lisa Johnson-Pratt
Director/Board Member presso TRACON PHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 31/12/2017
Profilo
Lisa R.
Johnson-Pratt is the founder of Ananias Ventures, which was founded in 2019.
She currently holds multiple positions, including Independent Director at TRACON Pharmaceuticals, Inc., Independent Director at Assembly Biosciences, Inc., Director at Internet Sciences, Inc., Director at Young People in Recovery, and Senior Vice President-Therapeutic Program at Aspen Neuroscience, Inc. Dr. Johnson-Pratt has held former positions such as Business Unit Director at Merck & Co., Inc. from 1996 to 2013, Global Marketing Director at Stiefel Laboratories, Inc. from 2013 to 2015, Head-Global Pharma Commercial Operations at GSK Plc from 2013 to 2019, Senior Vice President-New Product Strategy at Akcea Therapeutics, Inc. in 2020, and Senior Vice President-New Product Planning at Ionis Pharmaceuticals, Inc. from 2020 to 2022.
She obtained her undergraduate and doctorate degrees from Howard University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
Internet Sciences, Inc.
0.07% | 31/12/2023 | 13 500 ( 0.07% ) | 0 $ | 31/12/2017 |
01/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 | |
15/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Lisa Johnson-Pratt
Società | Posizione | Inizio |
---|---|---|
TRACON PHARMACEUTICALS, INC. | Director/Board Member | 02/03/2021 |
ASSEMBLY BIOSCIENCES, INC. | Director/Board Member | 20/05/2021 |
Young People in Recovery | Director/Board Member | - |
Internet Sciences, Inc. | Director/Board Member | 31/12/2022 |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2024 |
Precedenti posizioni note di Lisa Johnson-Pratt
Società | Posizione | Fine |
---|---|---|
IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2022 |
AKCEA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2020 |
GSK PLC | Corporate Officer/Principal | 01/07/2019 |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Sales & Marketing | 01/05/2015 |
░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Lisa Johnson-Pratt
Howard University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 5 |
---|---|
MERCK & CO., INC. | Health Technology |
IONIS PHARMACEUTICALS, INC. | Health Technology |
TRACON PHARMACEUTICALS, INC. | Health Technology |
GSK PLC | Health Technology |
ASSEMBLY BIOSCIENCES, INC. | Health Technology |
Aziende private | 5 |
---|---|
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Health Technology |
Akcea Therapeutics, Inc.
Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
Internet Sciences, Inc. | |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA. | Health Services |
Young People in Recovery |
- Borsa valori
- Insiders
- Lisa Johnson-Pratt